CLL Prognostic, Igvh Mutation Panel

CLL FISH testing provides information about the genetic profile of the patient's CLL cells. This genetic information can help doctors determine the appropriate treatment strategy and assess the prognosis. It's important to note that CLL is a heterogeneous disease, and FISH testing is one of several diagnostic and prognostic tools used to guide the management of this condition. The IgVH mutation status is an important part of CLL diagnosis and prognosis. It can help healthcare providers make treatment decisions and predict the likely course of the disease. Patients with mutated IgVH CLL typically have a slower disease progression and may not require treatment right away, whereas those with unmutated IgVH CLL may require more aggressive treatment sooner.